Our #lungtransplantation survey is still open. We are seeking input from transplant recipients, those referred/evaluated or on the waiting list and carers. Now available in 15 languages.

europeanlung.org/en/get-involved/surveys/...

The paper by Gerckens et al. discusses whether we can improve risk prediction after lung transplantation by personalizing lung function assessment #TXPforAll #LungTransplantation tinyurl.com/yc92w5yf

At the 2025 World Transplant Congress, experts gathered to discuss the future of #LungTransplantation, from cutting-edge research to life-saving solutions for advanced pulmonary disease. @stephenjmdphd #TXPforAll #Transplantation tinyurl.com/36hm5yja

🫁This study by Alavi et al. shows that static cold storage (SCS) increases Von Willebrand factor (VWF) expression in lung microvascular cells — potentially raising the risk of thrombosis after transplant. #TXPforAll #LungTransplantation #OpenAccess tinyurl.com/y6a5r2cd

Living with CLAD – when the life-saving treatment fails

𝗟𝗶𝘃𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗖𝗟𝗔𝗗 – 𝘄𝗵𝗲𝗻 𝘁𝗵𝗲 𝗹𝗶𝗳𝗲-𝘀𝗮𝘃𝗶𝗻𝗴 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗳𝗮𝗶𝗹𝘀​
Free Webinar​

Focused on patient perspective, respiratory rehabilitation, and palliative care in Chronic Lung Allograft Dysfunction.​

Open to transplant professionals, patients & caregivers.​
#CLAD #ESOTeducation #LungTransplantation

ISHLT Consensus Statement on STS and Lung Transplantation on the JHLT Podcast Joined by the three document leads, JHLT the Podcast discusses the latest Consensus Statement from ISHLT, exploring short telomere syndrome (STS) and lung transplantation.

Critically shortened #telomeres influence #InterstitialLungDisease.

Today on #JHLTThePodcast, we talk with the document leads of the latest #ISHLT Consensus Statement, Short Telomere Syndrome and #LungTransplantation.

www.ishlt.org/about/news-d...

#medsky #pulmsky #transplantsky

📢 A NEW #ISHLT Consensus Statement on short telomere syndrome (#STS) and #LungTransplantation is now available. 📖💡🫁 Check out the top 8️⃣ takeaways ⏬ Read the publication online at 🔗 https://bit.ly/4jrDYU4

#TransplantSky #MedSky

📢 A NEW #ISHLT Consensus Statement on the considerations for endpoints in #LungTransplantation clinical trials is now available. 📖💡🫁 Check out the top takeaways ⏬ and read the publication at the 🔗 bit.ly/3KKboR7

#TransplantSky #MedSky

Discover the latest in #LungTransplantation at the #ISHLT + @sts.org joint symposium next month at #STS2026. 🫁

📆 29 January | New Orleans, LA USA
✅ CME credits available
🎟️ One-day passes available for those who want to attend the symposium only!

➡️ Register at 🔗 bit.ly/4aonIkz

#TransplantSky

Chronic Lung Allograft Dysfunction Today Gaps, Challenges, and Future Directions in Lung Transplant Care

📢 Don’t miss ESOT’s #CLAD Webinar on 17 Dec!​
💡 Diagnosis, AI, biomarkers, and future trials​
🎓 Top experts across Europe​
🆓 Free | 🖱️ Register: go.esot.org/sp_clad_w1_2025​
​
#LungTransplantation w/ Sanofi​

📢 A NEW #ISHLT Consensus Statement on the perioperative use of #ECLS in #LungTransplantation is now available. 📖💡🫁 Part I of this three-part document focuses on preoperative considerations. Check out the top 🔟 takeaways ⏬ and read the publication at 🔗 https://bit.ly/4nZGvGK

🫁 New review article in AMJ Respiratory: Pediatric lung transplantation is evolving fast. From donor strategies to survival outcomes, this piece explores the innovations reshaping life-saving surgery for children.

Read: www.emjreviews.com/en-us/amj/re...

#LungTransplantation #Pediatrics

#LungTransplantation Following #Paraquat Poisoning: Time to Think
onlinelibrary.wiley.com/doi/10.1002/...

Halloran et al. shows that baseline lung allograft dysfunction (BLAD) after #lungtransplantation is not just linked to higher mortality—it is also associated with lower quality of life & reduced exercise capacity at 1 year post-transplant. #TXPforAll tinyurl.com/yw4thkae

Thrombotic Microangiopathy: A Devastating Complication... : Transplantation Direct enal, pulmonary, and overall survival of TMA in this patient group. Methods. We performed a case-control retrospective study of patients with TMA after LTX between January 1, 2000, and January 1, 2021. Controls were selected based on underlying lung disease, age, sex, cytomegalovirus risk, and immunosuppressive regimen. Overall survival data were collected for the whole lung transplant group. Results. A total of 29 TMA cases (2.9%) were identified out of 1025 LTx. Median time to development of TMA was 5.9 mo, 76% occurred in the first 12 mo. In the TMA group a higher rate of HLA donor-specific antibodies (11% versus 1%; P = 0.05), a lower median time to onset of chronic lung allograft dysfunction (37 versus 91 mo; P = 0.0017), a higher rate of cytomegalovirus infection (45% versus 19%; P = 0.02), and a higher prevalence of end-stage renal disease (24% versus 6%; P = 0.03) and overall death (97% versus 44%; P < 0.0001) was found. Diagnostic assessment of TMA was complete in 48% of patients, with Coombs testing missing in 52% and a disintegrin and metalloproteinase with thrombospondin type 1 motif 13 activity not assessed in 59%. Conclusions. TMA poses a significant risk of end-stage renal disease and mortality after LTx. Challenges remain in standardizing diagnostic criteria and understanding its pathogenesis, underscoring the need for unified protocols in diagnosis and standardized screening. This study identifies potential risk factors and temporal patterns for TMA occurrence, providing crucial insights for future treatment strategies....

TMA After Lung Transplant: A Deadly Complication. Risk factors include HLA donor-specific antibodies, CMV infection, and early chronic lung allograft dysfunction. @KU_Leuven @UZLeuven #LungTransplantation #TXPforAll tinyurl.com/vrvmsedp

According to Wijesinha et al., carefully increasing the use of older donors can reduce waitlist deaths while maintaining strong outcomes.@NorthwellHealth #TXPforAll #LungTransplantation #OpenAccess tinyurl.com/4bmcfct7

Priorities for lung transplantation research: a James Lind Alliance priority-setting partnership between patients, caregivers, and clinicians in Canada This study employed the James Lind Alliance Priority Setting Partnership methodology to identify and prioritize research priorities in lung transplantation through engagement of pre- and post-lung tra...

Excited to finally share our
James Lind Alliance
#Top10 Research Priorities for #LungTransplantation 🫁🔬👩🏽‍🔬

@ualberta.bsky.social
@ubcmedicine.bsky.social
@umontreal.ca @uhnresearch.ca @ucalgarymed.bsky.social

www.jhltopen.org/article/S295...

#Asbestosis Requiring #LungTransplantation in a Retired Hairdresser: An Occupational Exposure to Comb Through
onlinelibrary.wiley.com/doi/10.1002/...

Have you checked out the latest #ISHLT Standards + Guidelines? 🔎📖Two recently published documents cover:
❤️ Antibodies and #AMR in #HeartTransplantation
🤔 Postoperative considerations on the perioperative use of #ECLS in #LungTransplantation

View these + more at 🔗 https://bit.ly/45YUzbq

Check out "Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccinees" by Havlin et al. in this month's issue! doi.org/10.1016/j.aj... #lungtransplantation

"Clinical predictors for restrictive allograft syndrome: A nested case-control study" by Beeckmans et al. doi.org/10.1016/j.aj... #lungtransplantation

Pediatric lung transplantation in China is rare but growing, with bronchiolitis obliterans most common and 1-year survival reaching 80.6%.

#Meded #SoMe4PedSurg #Pediatrics #LungTransplantation #indication #PediatricSurgery #TransplantOutcomes

link.springer.com/article/10.1...

Published in this month's issue! Check out "Impact of continuous distribution as the allocation strategy on lung transplantation" by Banga et al. doi.org/10.1016/j.aj...
#organallocation #lungtransplantation

Wondering about rehabilitation for people after #LungTransplantation? Check out the upcoming webinar, FREE for Cardiorespiratory Division members of the Canadian Physiotherapy Association

How to define AMR and ACR in #lungtransplantation ? Standing room only at #ISHLT Acute Lung Allograft Dysfunction suggests that many share this question ! @ishlt.bsky.social #transplantresearch

Speakers at the head table and podium of a convention center meeting room. ISHLT2025 branding is on the podium and behind the stage, and the screen reads "Cardiogenic Shock"

It's #ISHLT2025 Pre-Conference day! More than 490 medical professionals have come together to dive deeper into #CardiogenicShock, #LungTransplantation, #LungFailure, #CTEPH, and #HealthEquity topics with experts from around the world. 💡🌏

(2/2) Sumiha is a 2025 Emerging and Pandemic Infections Consortium Doctoral Award recipient. Her research focuses on addressing gaps in understanding pleural immune cells. Congratulations Sumiha! 👏

#NextGenUHN #Immunology #LungTransplantation
@uoftmedicine.bsky.social

Multiple #Myeloma Complicated With #Bronchiolitis #Obliterans Syndrome After Allogeneic Haematopoietic Stem Cell Transplantation and Subsequently Underwent #LungTransplantation Successfully: A Case Report

This scoping #review shows that low to moderate opioid use pre-transplant doesn't harm #transplant outcomes, but chronic use post-transplant may lead to complications. @The_BMC #LungTransplantation #TXPforAll tinyurl.com/bdzx7hvy

The Potential of Pulmonary #Vasodilators as a Bridging Therapy for #LungTransplantation: Two Cases of #Interstitial #Pneumonia With #PulmonaryHypertension During the Waiting Period for Lung Transplantation